TYROSINE PHOSPHATASE PROTEIN INHIBITORS
VE6142020000071SUndetermined Publication Date: 2022-02-17ARRAY BIOPHARMA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- ARRAY BIOPHARMA INC
- Filing Date
- 2020-05-04
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
Compounds of formula IO, a stereoisomer, tautomer, prodrug, or pharmaceutically acceptable salt thereof, are provided, which are useful for the treatment of hyperproliferative diseases. Methods for using the compounds of formula IO, a stereoisomer, tautomer, prodrug, or pharmaceutically acceptable salt thereof, for the in vitro, in situ, and in vivo diagnosis, prevention, or treatment of such disorders in mammalian cells, or related pathological conditions, are disclosed.